SEC Form 4 · accession 0000899243-16-019748
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jordan G Naydenov
Director
Period of report
May 10, 2016
Accepted (ET)
May 12, 2016 · 1:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 10, 2016 | A | 1,000,000 | — | A | 5,097,242 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (right to buy)F1 | $1.35 | May 10, 2016 | A | 250,000 | A | May 10, 2016 | May 10, 2021 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1The reported securities were purchased together, as part of a private offering to accredited investors, at a combined price of $1.00 per share of common stock and a warrant covering 25% of the number of shares of common stock purchased.